Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6504-6513

  Guo, Li ^a   Normando, Eduardo M ^a   Nizari, Shereen ^a   Lara, David ^b   Francesca Cordeiro, M ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL SCANNING LASER OPHTHALMOSCOPY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; GLAUCOMA; IMAGE ANALYSIS; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; NONHUMAN; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHOTORECEPTOR OUTER SEGMENT; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RAT; RETINA DISEASE; RETINA NERVE CELL; RETINA THICKNESS; SCANNING LASER OPHTHALMOSCOPY; SENSITIVITY ANALYSIS; SPECTRAL SENSITIVITY; VISUAL SYSTEM PARAMETERS;

ANIMALS; DISEASE MODELS, ANIMAL; INTRAOCULAR PRESSURE; MALE; NERVE FIBERS; OCULAR HYPERTENSION; OPHTHALMOSCOPY; OPTIC DISK; RATS; RETINA; RETINAL DISEASES; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 79952576761     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5551     Document Type: Article

References (88)

1. Harwerth RS, Carter-Dawson L, Shen F, Smith EL 3rd, Crawford ML. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci. 1999;40:2242-2250.
2. Sommer A, Miller NR, Pollack I, Maumenee AE, George T. The nerve fiber layer in the diagnosis of glaucoma. Arch Ophthalmol. 1977;95:2149-2156.
3. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
4. van Velthoven ME, Verbraak FD, Yannuzzi LA, Rosen RB, Podoleanu AG, de Smet MD. Imaging the retina by en face optical coherence tomography. Retina. 2006;26:129-136.
5. Drexler W, Fujimoto JG. State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res. 2008;27:45-88.
6. Wood NEH, Guo L, Cordeiro MF. Imaging individual ganglion cells in the human retina. Glaucoma: Essentials in Ophthalmology. 2009;1-12.
7. Vizzeri G, Balasubramanian M, Bowd C, Weinreb RN, Medeiros FA, Zangwill LM. Spectral domain-optical coherence tomography to detect localized retinal nerve fiber layer defects in glaucomatous eyes. Opt Express. 2009;17:4004-4018.
8. Alencar LM, Zangwill LM, Weinreb RN, et al. Agreement for detecting glaucoma progression with the GDx guided progression analysis, automated perimetry, and optic disc photography. Ophthalmology. 2010;117:462-470.
9. Srinivasan VJ, Ko TH, Wojtkowski M, et al. Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2006;47:5522-5528.
10. Srinivasan VJ, Wojtkowski M, Fujimoto JG, Duker JS. In vivo measurement of retinal physiology with high-speed ultrahigh-resolution optical coherence tomography. Opt Lett. 2006;31:2308-2310.
11. Puvanathasan P, Forbes P, Ren Z, Malchow D, Boyd S, Bizheva K. High-speed, high-resolution Fourier-domain optical coherence tomography system for retinal imaging in the 1060 nm wavelength region. Opt Lett. 2008;33:2479-2481.
12. Kocaoglu OP, Uhlhorn SR, Hernandez E, et al. Simultaneous fundus imaging and optical coherence tomography of the mouse retina. Invest Ophthalmol Vis Sci. 2007;48:1283-1289.
13. Ruggeri M, Wehbe H, Jiao S, et al. In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2007;48: 1808-1814.
14. Kim KH, Puoris'haag M, Maguluri GN, et al. Monitoring mouse retinal degeneration with high-resolution spectral-domain optical coherence tomography. J Vis. 2008;8:17.1-11.
15. Nagata A, Higashide T, Ohkubo S, Takeda H, Sugiyama K. In vivo quantitative evaluation of the rat retinal nerve fiber layer with optical coherence tomography. Invest Ophthalmol Vis Sci. 2009; 50:2809-2815.
16. Xu J, Molday LL, Molday RS, Sarunic MV. In vivo imaging of the mouse model of X-linked juvenile retinoschisis with Fourier domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2009;50:2989-2993.
17. Fischer MD, Huber G, Beck SC, et al. Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography. PLoS One. 2009;4:e7507.
18. Huber G, Beck SC, Grimm C, et al. Spectral domain optical coherence tomography in mouse models of retinal degeneration. Invest Ophthalmol Vis Sci. 2009;50:5888-5895.
19. Nork TM, Ver Hoeve JN, Poulsen GL, et al. Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch Ophthalmol. 2000;118:235-245.
20. Panda S, Jonas JB. Decreased photoreceptor count in human eyes with secondary angle-closure glaucoma. Invest Ophthalmol Vis Sci. 1992;33:2532-2536.
21. Lei Y, Garrahan N, Hermann B, et al. Quantification of retinal transneuronal degeneration in human glaucoma: a novel multiphoton- DAPI approach. Invest Ophthalmol Vis Sci. 2008;49:1940-1945.
22. Kendell KR, Quigley HA, Kerrigan LA, Pease ME, Quigley EN. Primary open-angle glaucoma is not associated with photoreceptor loss. Invest Ophthalmol Vis Sci. 1995;36:200-205.
23. Hare WA, Ton H, Ruiz G, Feldmann B, Wijono M, WoldeMussie E. Characterization of retinal injury using ERG measures obtained with both conventional and multifocal methods in chronic ocular hypertensive primates. Invest Ophthalmol Vis Sci. 2001;42:127-136.
24. Wygnanski T, Desatnik H, Quigley HA, Glovinsky Y. Comparison of ganglion cell loss and cone loss in experimental glaucoma. Am J Ophthalmol. 1995;120:184-189.
25. Frishman LJ, Saszik S, Harwerth RS, et al. Effects of experimental glaucoma in macaques on the multifocal ERG: multifocal ERG in laser-induced glaucoma. Doc Ophthalmol. 2000;100:231-251.
26. Wang M, Hood DC, Cho JS, et al. Measurement of local retinal ganglion cell layer thickness in patients with glaucoma using frequency-domain optical coherence tomography. Arch Ophthalmol. 2009;127:875-881.
27. Ishikawa H, Stein DM, Wollstein G, Beaton S, Fujimoto JG, Schuman JS. Macular segmentation with optical coherence tomography. Invest Ophthalmol Vis Sci. 2005;46:2012-2017.
28. Tan O, Li G, Lu AT, Varma R, Huang D. Mapping of macular substructures with optical coherence tomography for glaucoma diagnosis. Ophthalmology. 2008;115:949-956.
29. Velten IM, Korth M, Horn FK. The a-wave of the dark adapted electroretinogram in glaucomas: are photoreceptors affected? Br J Ophthalmol. 2001;85:397-402.
30. Holopigian K, Seiple W, Mayron C, Koty R, Lorenzo M. Electrophysiological and psychophysical flicker sensitivity in patients with primary open-angle glaucoma and ocular hypertension. Invest Ophthalmol Vis Sci. 1990;31:1863-1868.
31. Vaegan, Graham SL, Goldberg I, Buckland L, Hollows FC. Flash and pattern electroretinogram changes with optic atrophy and glaucoma. Exp Eye Res. 1995;60:697-706.
32. Odom JV, Feghali JG, Jin JC, Weinstein GW. Visual function deficits in glaucoma: electroretinogram pattern and luminance nonlinearities. Arch Ophthalmol. 1990;108:222-227.
33. Raz D, Perlman I, Percicot CL, Lambrou GN, Ofri R. Functional damage to inner and outer retinal cells in experimental glaucoma. Invest Ophthalmol Vis Sci. 2003;44:3675-3684.
34. Bayer AU, Danias J, Brodie S, et al. Electroretinographic abnormalities in a rat glaucoma model with chronic elevated intraocular pressure. Exp Eye Res. 2001;72:667-677.
35. Bayer AU, Neuhardt T, May AC, et al. Retinal morphology and ERG response in the DBA/2NNia mouse model of angle-closure glaucoma. Invest Ophthalmol Vis Sci. 2001;42:1258-1265.
36. Fortune B, Bearse MA Jr, Cioffi GA, Johnson CA. Selective loss of an oscillatory component from temporal retinal multifocal ERG responses in glaucoma. Invest Ophthalmol Vis Sci. 2002;43:2638-2647.
37. Velten IM, Horn FK, Korth M, Velten K. The b-wave of the dark adapted flash electroretinogram in patients with advanced asymmetrical glaucoma and normal subjects. Br J Ophthalmol. 2001; 85:403-409.
38. Colotto A, Falsini B, Salgarello T, Iarossi G, Galan ME, Scullica L. Photopic negative response of the human ERG: losses associated with glaucomatous damage. Invest Ophthalmol Vis Sci. 2000;41: 2205-2211.
39. Holopigian K, Greenstein VC, Seiple W, Hood DC, Ritch R. Electrophysiologic assessment of photoreceptor function in patients with primary open-angle glaucoma. J Glaucoma. 2000;9:163-168.
40. Fortune B, Bui BV, Morrison JC, et al. Selective ganglion cell functional loss in rats with experimental glaucoma. Invest Ophthalmol Vis Sci. 2004;45:1854-1862.
41. Guo L, Salt TE, Maass A, et al. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest Ophthalmol Vis Sci. 2006;47: 626-633.
42. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96.
43. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci. 2005;46:175-182.
44. Guo L, Salt TE, Luong V, et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A. 2007;104:13444-13449.
45. Guo L, Tsatourian V, Luong V, et al. En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma. Br J Ophthalmol. 2005;89: 1210-1216.
46. Chauhan BC, Pan J, Archibald ML, LeVatte TL, Kelly ME, Tremblay F. Effect of intraocular pressure on optic disc topography, electroretinography, and axonal loss in a chronic pressure-induced rat model of optic nerve damage. Invest Ophthalmol Vis Sci. 2002; 43:2969-2976.
47. Campbell MC, Hughes A. An analytic, gradient index schematic lens and eye for the rat which predicts aberrations for finite pupils. Vision Res. 1981;21:1129-1148.
48. Sehi M, Ume S, Greenfield DS. Scanning laser polarimetry with enhanced corneal compensation and optical coherence tomography in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci. 2007;48:2099-2104.
49. Medeiros FA, Bowd C, Zangwill LM, Patel C, Weinreb RN. Detection of glaucoma using scanning laser polarimetry with enhanced corneal compensation. Invest Ophthalmol Vis Sci. 2007;48:3146-3153.
50. Townsend KA, Wollstein G, Schuman JS. Imaging of the retinal nerve fibre layer for glaucoma. Br J Ophthalmol. 2009;93:139-143.
51. Leung CK, Ye C, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: a study on diagnostic agreement with Heidelberg Retinal Tomograph. Ophthalmology. 2010;117:267-274.
52. Moreno-Montanes J, Anton A, Garcia N, Olmo N, Morilla A, Fallon M. Comparison of retinal nerve fiber layer thickness values using Stratus Optical Coherence Tomography and Heidelberg Retina Tomograph-III. J Glaucoma. 2009;18:528-534.
53. Nassif N, Cense B, Park BH, et al. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett. 2004;29:480-482.
54. Wojtkowski M, Bajraszewski T, Gorczynska I, et al. Ophthalmic imaging by spectral optical coherence tomography. Am J Ophthalmol. 2004;138:412-419.
55. Kim JS, Ishikawa H, Gabriele ML, et al. Retinal nerve fiber layer thickness measurement comparability between time domain optical coherence tomography (OCT) and spectral domain OCT. Invest Ophthalmol Vis Sci. 2010;51:896-902.
56. Janssen P, Naskar R, Moore S, Thanos S, Thiel H. Evidence for glaucoma induced horizontal cell alteration in the human retina. Ger J Ophthalmol. 1997;5:378-385.
57. Moon JI, Kim IB, Gwon JS, et al. Changes in retinal neuronal populations in the DBA/2J mouse. Cell Tissue Res. 2005;320: 51-59.
58. Pelzel HR, Schlamp CL, Poulsen GL, Ver Hoeve JA, Nork TM, Nickells RW. Decrease of cone opsin mRNA in experimental ocular hypertension. Mol Vis. 2006;12:1272-1282.
59. Kanis MJ, Lemij HG, Berendschot TT, van de Kraats J, van Norren D. Foveal cone photoreceptor involvement in primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2010;248:999-1006.
60. Kerrigan-Baumrind L, Quigley H, Pease M, Kerrigan D, Mitchell R. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41:741-748.
61. Rechtman E, Harris A. Choroidal blood flow regulation and possible implications to glaucoma. Clin Exp Ophthalmol. 2008;36:111-112.
62. Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol. 2007;52(suppl 2):S144-S154.
63. Kerr J, Nelson P, O'Brien C. A comparison of ocular blood flow in untreated primary open-angle glaucoma and ocular hypertension. Am J Ophthalmol. 1998;126:42-51.
64. Kubota T, Jonas JB, Naumann GO. Decreased choroidal thickness in eyes with secondary angle closure glaucoma: an aetiological factor for deep retinal changes in glaucoma? Br J Ophthalmol. 1993;77:430-432.
65. Tanito M, Itai N, Ohira A, Chihara E. Reduction of posterior pole retinal thickness in glaucoma detected using the Retinal Thickness Analyzer. Ophthalmology. 2004;111:265-275.
66. Asrani S, Challa P, Herndon L, Lee P, Stinnett S, Allingham RR. Correlation among retinal thickness, optic disc, and visual field in glaucoma patients and suspects: a pilot study. J Glaucoma. 2003; 12:119-128.
67. Zeimer R, Asrani S, Zou S, Quigley H, Jampel H. Quantitative detection of glaucomatous damage at the posterior pole by retinal thickness mapping: a pilot study. Ophthalmology. 1998;105:224-231.
68. Cvenkel B. Retinal thickness at the posterior pole in glaucoma and ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2004; 242:920-925.
69. Hernandez MR, Pena JD, Selvidge JA, Salvador-Silva M, Yang P. Hydrostatic pressure stimulates synthesis of elastin in cultured optic nerve head astrocytes. Glia. 2000;32:122-136.
70. Greenfield DS, Bagga H, Knighton RW. Macular thickness changes in glaucomatous optic neuropathy detected using optical coherence tomography. Arch Ophthalmol. 2003;121:41-46.
71. Ojima T, Tanabe T, Hangai M, Yu S, Morishita S, Yoshimura N. Measurement of retinal nerve fiber layer thickness and macular volume for glaucoma detection using optical coherence tomography. Jpn J Ophthalmol. 2007;51:197-203.
72. Bagga H, Greenfield DS, Knighton RW. Macular symmetry testing for glaucoma detection. J Glaucoma. 2005;14:358-363.
73. Parikh RS, Parikh SR, Sekhar GC, Prabakaran S, Babu JG, Thomas R. Normal age-related decay of retinal nerve fiber layer thickness. Ophthalmology. 2007;114:921-926.
74. Guedes V, Schuman JS, Hertzmark E, et al. Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology. 2003;110:177-189.
75. Sehi M, Grewal DS, Sheets CW, Greenfield DS. Diagnostic ability of Fourier-domain vs time-domain optical coherence tomography for glaucoma detection. Am J Ophthalmol. 2009;148:597-605.
76. Cohen MJ, Kaliner E, Frenkel S, Kogan M, Miron H, Blumenthal EZ. Morphometric analysis of human peripapillary retinal nerve fiber layer thickness. Invest Ophthalmol Vis Sci. 2008;49:941-944.
77. Frenkel S, Morgan JE, Blumenthal EZ. Histological measurement of retinal nerve fibre layer thickness. Eye. 2005;19:491-498.
78. Fitzgibbon T, Taylor SF. Retinotopy of the human retinal nerve fibre layer and optic nerve head. J Comp Neurol. 1996;375:238-251.
79. Danias J, Shen F, Goldblum D, et al. Cytoarchitecture of the retinal ganglion cells in the rat. Invest Ophthalmol Vis Sci. 2002;43:587-594.
80. Fukuda Y. A three-group classification of rat retinal ganglion cells: histological and physiological studies. Brain Res. 1977;119:327-334.
81. Salinas-Navarro M, Mayor-Torroglosa S, Jimenez-Lopez M, et al. A computerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats. Vision Res. 2009;49:115-126.
82. Quigley HA. Early detection of glaucomatous damage, II: changes in the appearance of the optic disk. Surv Ophthalmol. 1985;30: 111, 117-126.
83. Jonas JB, Fernandez MC, Sturmer J. Pattern of glaucomatous neuroretinal rim loss. Ophthalmology. 1993;100:63-68.
84. Harizman N, Oliveira C, Chiang A, et al. The ISNT rule and differentiation of normal from glaucomatous eyes. Arch Ophthalmol. 2006;124:1579-1583.
85. Cordeiro MF, Guo L, Luong V, et al. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A. 2004;101:13352-13356.
86. Guo L, Cordeiro MF. Assessment of neuroprotection in the retina with DARC. Prog Brain Res. 2008;173:437-450.
87. Buckingham BP, Inman DM, Lambert W, et al. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci. 2008;28:2735-2744.
88. Whitmore AV, Libby RT, John SW. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalized processes? Prog Retin Eye Res. 2005;24:639-662.